Once-daily dosing of enoxaparin (a low molecular weight heparin) in prevention of deep vein thrombosis after total hip replacement. 1990

A Planès, and N Vochelle, and M Fagola, and M Bellaud, and J Feret, and C Salzard, and M Planès
Clinique Radio-Chirurgicale du Mail, La Rochelle, France.

The main results of three successive prospective clinical trials which represent the successive steps in the definition of once-daily dosing of enoxaparin in elective hip surgery are demonstrated. In the first trial, a dose of 40 mg/day (4000 anti-Factor Xa IU), in one or two subcutaneous injections, was preferred to a dose of 60 mg because it gave the same efficacy with a better tolerance. In a second, randomized double-blind trial, the two modes of administration of a dose of 40 mg, in one or two injections daily, were found to be equivalent with regard to tolerance and efficacy. In a third prospective, controlled, randomized, double-blind multicentre trial, once-daily dosing of enoxaparin at the dose of 40 mg was found superior to 5000 IU of unfractionated heparin tds with regard to tolerance and efficacy. It is concluded that the dose of 40 mg/day, begun 12 h pre-operatively, gives the best benefit:risk ratio in elective hip surgery.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010690 Phlebography Radiographic visualization or recording of a vein after the injection of contrast medium. Venography,Phlebographies,Venographies
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D005602 France A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris. Corsica,Saint Pierre and Miquelon,Miquelon and Saint Pierre,Miquelon and St. Pierre,St. Pierre and Miquelon

Related Publications

A Planès, and N Vochelle, and M Fagola, and M Bellaud, and J Feret, and C Salzard, and M Planès
August 1991, Archives of internal medicine,
A Planès, and N Vochelle, and M Fagola, and M Bellaud, and J Feret, and C Salzard, and M Planès
May 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
A Planès, and N Vochelle, and M Fagola, and M Bellaud, and J Feret, and C Salzard, and M Planès
April 1991, The Journal of bone and joint surgery. American volume,
A Planès, and N Vochelle, and M Fagola, and M Bellaud, and J Feret, and C Salzard, and M Planès
September 1991, BMJ (Clinical research ed.),
A Planès, and N Vochelle, and M Fagola, and M Bellaud, and J Feret, and C Salzard, and M Planès
September 2010, Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery,
A Planès, and N Vochelle, and M Fagola, and M Bellaud, and J Feret, and C Salzard, and M Planès
November 1989, The British journal of clinical practice,
A Planès, and N Vochelle, and M Fagola, and M Bellaud, and J Feret, and C Salzard, and M Planès
July 1991, Thrombosis research,
A Planès, and N Vochelle, and M Fagola, and M Bellaud, and J Feret, and C Salzard, and M Planès
January 1992, Thrombosis and haemostasis,
A Planès, and N Vochelle, and M Fagola, and M Bellaud, and J Feret, and C Salzard, and M Planès
August 1976, Thrombosis and haemostasis,
A Planès, and N Vochelle, and M Fagola, and M Bellaud, and J Feret, and C Salzard, and M Planès
August 2004, The Journal of bone and joint surgery. British volume,
Copied contents to your clipboard!